Sharing Insights and Best Practices

Our service is now used by hundreds of hospital clients around the world. A more distinctive identity is needed to distinguish us as we continue to grow, and extend our clinical guidance capabilities. The name Firstline better supports our role as being the go-to source for delivering your hospital's preferred clinical guidance.

Antimicrobial Stewardship reduces inappropriate antimicrobial use and focuses on improving patient outcomes while combatting antimicrobial resistance. ID/ASP Pharmacist, Mira Maximos, shares different strategies to help your practice improve outcomes and reduce adverse effects associated with antimicrobials.

Insights on antimicrobial stewardship goals around the world, beneficial outcomes of stewardship and great resources to help advance your ASP program.

Antimicrobial Stewardship programs work tirelessly to change prescribing behavior amongst their providers. Sometimes it’s an uphill battle. We spoke with Pediatric ASP team lead, Dr. Nicole Le Saux, to get her insights on how she is able to change prescribing behavior by evolving her guidelines as part of a conversation with her providers.

Introducing our newest tool: Community Content Library. This software helps power your antimicrobial stewardship program and save you time. Community Content allows you to easily browse, copy and adapt guidelines from all the thousands of vetted clinical guidelines housed in Firstline, created by the many hospitals we support.

We recently interviewed Dr. Tiffany Wong and Dr. Chelsea Elwood, both of BC Women's and Children's Hospital in Vancouver, Canada to gain insights on this stewardship challenge and learn more about how they are using Firstline as an intervention tool to address it.

VITT type blood clots are a rare adverse event following administration of COVID-19 vaccines that use the adenoviral vector including the AstraZeneca/COVISHIELD as well as the Johnson & Johnson vaccines.

The keys to building a great antimicrobial stewardship program - an interview with Dr. Shaqil Peermohamed.

Currently, there are no specific risk factors, such as age, gender or previous medical history of clotting disorders, identified for the observed rare events. There is still no proven causal link with the vaccine; however, further analysis is ongoing.

Amongst the excitement about the public rollout of these vaccines, an important question is being asked by those looking to be vaccinated: “Which vaccine should I get?”

We are excited to introduce our new blog where we will share up to date evidence, clinical perspectives and best practices in Infectious Diseases and Antimicrobial Stewardship.